14 Intangible assets and goodwill

EUR 000

Goodwill

Software

Internally developed software

Licences

Total

Balance at 1 October 2021:

Cost

6,395

17,765

3,971

544

28,675

Accumulated amortization and impairment

12,649

1,764

16

14,429

Carrying amount

6,395

5,116

2,207

528

14,246

Movements during 2021/2022:

Additions

1,428

146

1,574

Amortization

-962

-776

-1,738

Disposals cost

-528

-528

Impairment

-10,839

-62

-544

-11,445

Disposals accumulated amortization

10,839

62

544

11,445

Balance at 30 September 2022

6,395

5,582

1,577

13,554

Cost

6,395

8,354

4,055

18,804

Accumulated amortization and impairment

2,772

2,478

5,250

Balance at 30 September 2022

6,395

5,582

1,577

13,554

Movements during 2022/2023:

Additions

2,243

335

2,578

Amortization

-1,245

-894

-2,139

Impairment

-88

-88

Disposals cost

-164

-367

-531

Disposals accumulated amortization

164

367

531

Balance at 30 September 2023

6,395

6,492

1,018

13,905

Cost

6,395

10,433

4,023

20,851

Accumulated amortization and impairment

3,941

3,005

6,946

Balance at 30 September 2023

6,395

6,492

1,018

13,905

Software

Software mainly relates to back-office systems. The remaining period of amortization as at 30 September 2023 is two to eight years (30 September 2022: two to eight years).

Internally developed software

Internally developed software mainly relates to digital risk software. During 2022/2023 an amount of EUR 335 was capitalized (2021/2022: EUR 146).

Impairment loss

In 2022/2023, an impairment of EUR 88 was recorded with respect to backup software that became economically obsolete and is no longer in use.

The impairment loss in 2021/2022 relates to a perpetual license in respect of cultural software, consisting of an app that was used to provide examples on how to surpass cultural differences when working together. The app became economically obsolete and is no longer in use. For this reason, the license was impaired to nil.

Impairment testing for cash-generating units containing goodwill

For the purpose of impairment testing, goodwill is allocated to the Group’s cash-generating units (CGUs). The aggregate carrying amounts of goodwill allocated to each CGU are as follows:

EUR 000

30 September 2023

30 September 2022

KPMG Advisory

6,395

6,395

On an annual basis, the Group carries out impairment tests on capitalized goodwill, which are based on the estimated cash flows of the related CGU. The CGU represents the lowest level within the Group at which the goodwill is monitored for internal management purposes, which is not higher than the Group’s operating segment as reported in Note 4 Segment reporting. The recoverable amount of the relevant CGU is determined on the basis of its value in use. Determination of the value in use is performed by using estimated future cash flows, based on the 2022/2023 business plan approved by the Board of Management and further financial projections for the financial years through 2024/2025. Cash flows after this period are extrapolated by using a growth rate to calculate the terminal value.

The key assumptions in the cash flow projections are:

  • Total revenue growth and result development, which is based on historical performance, expected future market developments, and the 2023/2024 business plan. For the period 2023/2024, a real revenue growth of 9.0% is included. For the period thereafter, KPMG has used a real growth of 0%, in addition to an inflation component based on inflation forecasts derived from the Economist Intelligence Group (IEU);

  • A discount rate of 8.1% (2021/2022: 8.1%) to calculate the present value of the estimated future cash flows, to which pre-tax discount rates have been applied. The pre-tax discount rates are determined on the basis of the individual post-tax weighted average cost of capital calculated;

  • An indefinite growth rate, including an inflation correction, based on the lowest of the risk-free rate assumed in the weighted average cost of capital and the long-term inflation forecasts derived from IEU: 2% (2021/2022: 2%).

The values assigned to the key assumptions represent management’s assessment of future trends in the respective markets, and are based on both external and internal sources (historical and forward-looking data).

A sensitivity analysis has been performed, taking a change in the pre‑tax weighted average cost of capital and the revenue growth expectations into consideration. An increase of 5 percentage points in the discount rate confirms sufficient headroom in the cash-generating unit.

Based on the outcome of the impairment tests, no impairments have been recorded.